Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Red light therapy vs atropine in myopic children
NCT05203432Unknown
- Start
- Feb 2022
- Primary completion
- Jun 2024
- Countries
- 1
01
Overview
Randomised, open-label trial in myopia (2 arms). Primary endpoint: Changes of axial length at 1 year. Status: unknown.
02
Conditions
myopia
Beyond the preview
Go deeper on NCT05203432.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05203432.